Belgium
Axithra, established in 2023, is a novel biotechnology venture originating as a spin-off from Ghent University and imec in Belgium. The company is advancing the field of healthcare with its platform designed for Rapid Therapeutic Drug Monitoring.
Axithra's flagship technology employs proprietary optical and photonics systems to precisely track and measure drug concentrations in the bloodstream. This innovation empowers physicians to offer personalized treatment, beginning with a focus on fine-tuning beta-lactam antibiotics for ICU patients. Such precision could significantly elevate patient care by tailoring therapies to individual needs in real-time.
The startup recently secured a €10.00M seed investment on 01 September 2023. The funding round was led by a consortium of investors, including Kurma Partners, Imec.xpand, Noshaq, QBIC, WE Venture, Hamamatsu Iwata Shinkin Bank, White Fund, Werfen, and Wallonie Entreprendre.
